One challenge to HCV elimination through therapeutic intervention is reinfection. The aim of this analysis was to calculate the incidence of HCV reinfection among both HIV-positive and HIV-negative individuals treated for recent HCV infection (estimated infection duration <18 months). Individuals with recent HCV infection who achieved an end-of-treatment response in four open-label studies between 2004 and 2015 in Australia and New Zealand were assessed for HCV reinfection, confirmed by sequencing of the Core-E2 and/or NS5B regions. Reinfection incidence was calculated using person-time of observation. Exact Poisson regression analysis was used to assess factors associated with HCV reinfection. The cohort at risk for reinfection (n=120; 83%...
BACKGROUND: Human immunodeficiency virus (HIV)-positive men who have sex with men (MSM) are at high ...
BACKGROUND: Human immunodeficiency virus (HIV)-positive men who have sex with men (MSM) are at high ...
Objectives: Although direct-acting antivirals (DAAs) can clear HCV in nearly all HIV/HCV-coinfected ...
One challenge to HCV elimination through therapeutic intervention is reinfection. The aim of this an...
One challenge to HCV elimination through therapeutic intervention is reinfection. The aim of this an...
OBJECTIVE Reinfection poses a challenge to HCV elimination. This analysis assessed incidence of, ...
OBJECTIVE Reinfection poses a challenge to HCV elimination. This analysis assessed incidence of, ...
OBJECTIVE Reinfection poses a challenge to HCV elimination. This analysis assessed incidence of, ...
Abstract Background The aim of this analysis was to calculate the incidence of hepatitis C virus (HC...
Infection with hepatitis C virus (HCV) does not induce protective immunity, and re-exposure to HCV c...
BACKGROUND & AIMS: Direct-acting antiviral therapies (DAA) are an important tool for hepatitis C vir...
BACKGROUND & AIMS: Direct-acting antiviral therapies (DAA) are an important tool for hepatitis C...
OBJECTIVE: Liver disease secondary to hepatitis C virus (HCV) infection in the context of HIV infect...
Background: People remain at risk of reinfection with hepatitis C virus (HCV), even after clearance ...
Objectives: Although direct-acting antivirals (DAAs) can clear HCV in nearly all HIV/HCV-coinfected ...
BACKGROUND: Human immunodeficiency virus (HIV)-positive men who have sex with men (MSM) are at high ...
BACKGROUND: Human immunodeficiency virus (HIV)-positive men who have sex with men (MSM) are at high ...
Objectives: Although direct-acting antivirals (DAAs) can clear HCV in nearly all HIV/HCV-coinfected ...
One challenge to HCV elimination through therapeutic intervention is reinfection. The aim of this an...
One challenge to HCV elimination through therapeutic intervention is reinfection. The aim of this an...
OBJECTIVE Reinfection poses a challenge to HCV elimination. This analysis assessed incidence of, ...
OBJECTIVE Reinfection poses a challenge to HCV elimination. This analysis assessed incidence of, ...
OBJECTIVE Reinfection poses a challenge to HCV elimination. This analysis assessed incidence of, ...
Abstract Background The aim of this analysis was to calculate the incidence of hepatitis C virus (HC...
Infection with hepatitis C virus (HCV) does not induce protective immunity, and re-exposure to HCV c...
BACKGROUND & AIMS: Direct-acting antiviral therapies (DAA) are an important tool for hepatitis C vir...
BACKGROUND & AIMS: Direct-acting antiviral therapies (DAA) are an important tool for hepatitis C...
OBJECTIVE: Liver disease secondary to hepatitis C virus (HCV) infection in the context of HIV infect...
Background: People remain at risk of reinfection with hepatitis C virus (HCV), even after clearance ...
Objectives: Although direct-acting antivirals (DAAs) can clear HCV in nearly all HIV/HCV-coinfected ...
BACKGROUND: Human immunodeficiency virus (HIV)-positive men who have sex with men (MSM) are at high ...
BACKGROUND: Human immunodeficiency virus (HIV)-positive men who have sex with men (MSM) are at high ...
Objectives: Although direct-acting antivirals (DAAs) can clear HCV in nearly all HIV/HCV-coinfected ...